miR-485-5p inhibits the progression of breast cancer cells by negatively regulating MUC1

Xiaowen Wang,Xin Zhou,Fanye Zeng,Xiaotang Wu,Hua Li
DOI: https://doi.org/10.1007/s12282-020-01075-2
2020-03-06
Breast Cancer
Abstract:To investigate the mechanism of miR-485-5p inhibiting breast cancer cells by targeting MUC1.Differentially expressed genes (DEGs) in breast cancer tissues were analyzed using breast cancer tissue microarrays (TMA) in the GEO database. Differential expression of MUC1 in breast cancer tissue samples was detected by TCGA database. qRT-PCR was used to detect the expression of MUC1 and miR-485-5p in human normal breast epithelial cell lines and human breast cancer cell lines. Bioinformatics was applied to analyze targeted binding site of miR-485-5p and MUC1 and their targeted relationship was identified by dual luciferase assay. The proliferation ability of breast cancer cells was detected by CCK-8 assay. Cell apoptosis was detected by flow cytometry. The ability of cell migration was measured by scratch healing test. Transwell assay was used to detect the invasion ability of cells. The protein expression levels of MUC1 and EMT-related molecules (E-cadherin, N-cadherin and Vimentin) were detected by Western blot.
oncology,obstetrics & gynecology
What problem does this paper attempt to address?